Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part II: curcumin derivatives in cancer and neurodegeneration

References

• Gupta SC, Sung B, Kim JH, et al. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol Nutr Food Res. 2013 Sep;57(9):1510–1528.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Koh W, et al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012 Mar;39(3):283–299.
   PubMed Web of Science ®Google Scholar
• Di Martino RM, Luppi B, Bisi A, et al. Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part I: curcumin. Expert Opin Ther Pat. 2017 May;27(5):579–590.
   PubMed Web of Science ®Google Scholar
• Agrawal DK, Mishra PK. Curcumin and its analogues: potential anticancer agents. Med Res Rev. 2010 Sep;30(5):818–860.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007 Nov-Dec;4(6):807–818.
   PubMed Web of Science ®Google Scholar
• Qian X. Inventor USA. assignee. Curcumin derivs. As Antitumor agents patent WO2013033250A1. 2013.
   Google Scholar
• Emons G, Ortmann O, Schulz KD, et al. Growth-inhibitory actions of analogues of luteinizing hormone releasing hormone on tumor cells. Trends Endocrinol Metab. 1997 Nov;8(9):355–362.
   PubMed Web of Science ®Google Scholar
• Hansel W, Aggarwal S, Hammer RP. Inventors; Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, USA. assignee. Curcumin conjugates, particularly with LHRH, LH or chorionic gonadotropin, for treating and preventing hormone receptor-expressing cancers. Patent WO2010033580A2. 2010.
   Google Scholar
• Mao H, Wan J, Pan Y. Facile and diastereoselective synthesis of beta-acetamido ketones and keto esters via direct Mannich-type reaction. Tetrahedron. 2009 Jan 31;65(5):1026–1032.
   Web of Science ®Google Scholar
• Gyuris M, Puskas L, Kanizsai I. et al., Inventors; Avidin Kft., Hung. assignee. Preparation of curcumin derivatives for treatment of cancer and inflammation patent. HU2011000532A2. 2013.
   Google Scholar
• Golub LM, Johnson F, Botchkina GI. et al. Inventors; The research foundation of state university of New York, USA; Chem-master international, Inc. assignee. Polyenolic zinc-binding agents (Pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug activity patent. WO2014005089A2. 2014.
   Google Scholar
• Kuznetsova L, Chen J, Sun L, et al. Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents. Bioorg Med Chem Lett. 2006 Feb 15;16(4):974–977.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gu Y, Lee HM, et al. Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins. Curr Med Chem. 2012 Sep;19(25):4348–4358.
   PubMed Web of Science ®Google Scholar
• Ross RK, Coetzee GA, Pearce CL, et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Eur Urol. 1999;35(5–6):355–361.
   PubMed Web of Science ®Google Scholar
• Lai KP, Huang CK, Chang YJ, et al. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. Am J Pathol. 2013 Feb;182(2):460–473.
   PubMed Web of Science ®Google Scholar
• Shih C, Shi Q, Wang H-K. Inventors; AndroScience corporation, USA. assignee. Compounds with (1E,6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, preparation and uses thereof patent. US20130338160A1. 2013.
   Google Scholar
• Wang YJ, Pan MH, Cheng AL, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 1997 Aug;15(12):1867–1876.
   PubMed Web of Science ®Google Scholar
• Gersch M, Kreuzer J, Sieber SA. Electrophilic natural products and their biological targets. Nat Prod Rep. 2012 Jun;29(6):659–682.
   PubMed Web of Science ®Google Scholar
• Adams BK, Cai JY, Armstrong J, et al. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anti-Cancer Drugs. 2005 Mar;16(3):263–275.
   PubMed Web of Science ®Google Scholar
• Brown A, Shi Q, Moore TW, et al. Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties. J Med Chem. 2013 May 9;56(9):3456–3466.
   PubMed Web of Science ®Google Scholar
• Awasthi V, Lagisetty P, Agashe H. Inventors; the University of Oklahoma, USA. assignee. Antiproliferative compositions comprising curcumin analogs and methods of producing and using same patent. US20120288555A1. 2012.
   Google Scholar
• Fawzy IM, Youssef KM, Abouzid KAM, et al. Inventors; Egypt. assignee. Preparation of novel curcumin analogs with anticancer activity patent. WO2015067282A1. 2015.
   Google Scholar
• Rawat DS, Wang B, Kumar N, et al. Inventors; Georgia state university research foundation, Inc., USA; University of Delhi. assignee. Curcumin derivatives useful in treatment of cancer and their preparation patent. WO2014022660A1. 2014.
   Google Scholar
• Cole GM, Teter B, Frautschy SA. Neuroprotective effects of curcumin. Adv Exp Med Biol. 2007;595:197–212.
   PubMed Web of Science ®Google Scholar
• Monroy A, Lithgow GJ, Alavez S. Curcumin and neurodegenerative diseases. Biofactors. 2013 Jan-Feb;39(1):122–132.
   PubMed Web of Science ®Google Scholar
• Hardy J. Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis. 2006;9(3 Suppl):151–153.
   PubMed Web of Science ®Google Scholar
• Llorens-Martín M, Jurado J, Hernández F, et al. GSK-3β, a pivotal kinase in Alzheimer disease. Front Mol Neurosci. 2014;7:46.
   PubMed Web of Science ®Google Scholar
• Pimplikar SW. Neuroinflammation in Alzheimer’s disease: from pathogenesis to a therapeutic target. J Clin Immunol. 2014 Jul;34(Suppl 1):S64–S69.
   PubMed Web of Science ®Google Scholar
• Murphy RM. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Biochim Biophys Acta. 2007 Aug;1768(8):1923–1934.
   PubMed Web of Science ®Google Scholar
• Pellarin R, Caflisch A. Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol. 2006 Jul 21;360(4):882–892.
   PubMed Web of Science ®Google Scholar
• Wang X, Kim JR, Lee SB, et al. Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer’s disease Drosophila models. BMC Complement Altern Med. 2014;14:88.
   PubMed Web of Science ®Google Scholar
• Di Martino RM, De Simone A, Andrisano V, et al. Versatility of the curcumin scaffold: discovery of potent and balanced dual BACE-1 and GSK-3beta inhibitors. J Med Chem. 2016 Jan 28;59(2):531–544.
   PubMed Web of Science ®Google Scholar
• Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008 Feb 15;75(4):787–809.
   PubMed Web of Science ®Google Scholar
• Ferrari E, Benassi R, Sacchi S, et al. Curcumin derivatives as metal-chelating agents with potential multifunctional activity for pharmaceutical applications. J Inorg Biochem. 2014 Oct;139:38–48.
   PubMed Web of Science ®Google Scholar
• Gokaraju GR, Gokaraju RR, Golakoti T, et al., Inventors; Laila Pharmaceuticals Pvt. Ltd., India. assignee. Method of inhibition of beta-secretase by using bis-O-demethylcurcumin for the prevention, management and treatment of neurodegenerative diseases patent. WO2015186144A2. 2015.
   Google Scholar
• Hong S, Leroueil PR, Majoros IJ, et al. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol. 2007 Jan;14(1):107–115.
   PubMed Web of Science ®Google Scholar
• Antimisiari S, Mourtas S, Niaraki A, et al., Inventors; University of Patras, Greece; Universita degli Studi di Milano - Bicocca; Antimisiari sofia. assignee. Curcumin derivatives with improved physicochemical properties and nanoliposomes surface-decorated with the derivatives with very high affinity for amyloid-β 1-42 peptide patent. EP2436673A1. 2012.
   Google Scholar
• Kolb HC, Sharpless KB. The growing impact of click chemistry on drug discovery. Drug Discov Today. 2003 Dec 15; 8(24):1128–1137.
   PubMed Web of Science ®Google Scholar
• Nalivaeva NN, Belyaev ND, Kerridge C, et al. Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease. Front Aging Neurosci. 2014 Sep;17:6.
   Google Scholar
• Chen RPY, Wang SS-S, Hu C-J, et al. Inventors; Academia Sinica, Taiwan. assignee. Fluorogenic assay substrates for detection of amyloid β-degrading enzymes in the diagnosis of dementia patent. US20130102498A1. 2013.
   Google Scholar
• Chen PT, Liao TY, Hu CJ, et al. A highly sensitive peptide substrate for detecting two Aß-degrading enzymes: neprilysin and insulin-degrading enzyme. J Neurosci Methods. 2010 Jun;190(1):57–62.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015 Jun;16(6):345–357.
   PubMed Web of Science ®Google Scholar
• Martini-Stoica H, Xu Y, Ballabio A, et al. The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 2016 Apr;39(4):221–234.
   PubMed Web of Science ®Google Scholar
• Li M, Song J, Zeng Y, et al., Inventors; Hong Kong Baptist University, Hong Kong. assignee. MTOR-independent activator of TFEB for autophagy enhancement and uses thereof patent. US20150250741A1. 2015.
   Google Scholar
• Meunier B. Hybrid molecules with a dual mode of action: dream or reality? Acc Chem Res. 2007;41(1):69–77.
   PubMed Web of Science ®Google Scholar
• Zhang S. Inventor Virginia Commonwealth University, USA. assignee. Hybrid compounds of curcumin and melatonin as neuroprotectants for neurodegenerative disorders patent. WO2015069970A1. 2015.
   Google Scholar
• Cardinali DP, Furio AM, Brusco LI. Clinical aspects of melatonin intervention in Alzheimer’s disease progression. Curr Neuropharmacol. 2010 Sep;8(3):218–227.
   PubMed Web of Science ®Google Scholar
• Zhang S, Guo TL. Inventors; Virginia commonwealth university, USA. assignee. Bivalent multifunctional ligands targeting aβ oligomers as treatment for Alzheimer’s disease patent. WO2012012257A2. 2012.
   Google Scholar
• Patra D, Barakat C. Synchronous fluorescence spectroscopic study of solvatochromic curcumin dye. Spectrochim Acta A Mol Biomol Spectrosc. 2011 Sep;79(5):1034–1041.
   PubMed Web of Science ®Google Scholar
• Koronyo Y, Salumbides BC, Black KL, et al. Alzheimer’s disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment. Neurodegener Dis. 2012;10(1–4):285–293.
   PubMed Web of Science ®Google Scholar
• Mohorko N, Repovs G, Popovic M, et al. Curcumin labeling of neuronal fibrillar tau inclusions in human brain samples. J Neuropathol Exp Neurol. 2010 Apr;69(4):405–414.
   PubMed Web of Science ®Google Scholar
• Black KL, Ljubimova JY, Ljubimov AV, et al. Inventors; Cedars-sinai medical center, USA. assignee. Polymalic acid-based nanoconjugates and their preparation for contrast agent targeting and imaging patent. WO2012139030A1. 2012.
   Google Scholar
• Raja K, Banerjee P, Auerbach A, et al. Inventors; Research foundation of the City University of New York, USA. Assignee. Preparation of curcumin and tetrahydrocurcumin derivatives patent WO2008045534A2. 2008.
   Google Scholar
• Ran C, Zhang X, Moore A Inventors; The general hospital corporation, USA. Assignee. Preparation of curcumin analogs for diagnosis and therapy patent. WO2014025808A1. 2014.
   Google Scholar
• Ran C, Xu X, Raymond SB, et al. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. J Am Chem Soc. 2009 Oct 28;131(42):15257–15261.
   PubMed Web of Science ®Google Scholar
• Ran C, Moore A. Spectral unmixing imaging of wavelength-responsive fluorescent probes: an application for the real-time report of amyloid Beta species in Alzheimer’s disease. Mol Imaging Biol. 2012 Jun;14(3):293–300.
   PubMed Web of Science ®Google Scholar